These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 868900)

  • 1. Mechanisms of resistance to aminoglycosides.
    Davies J; Courvalin P
    Am J Med; 1977 Jun; 62(6):868-72. PubMed ID: 868900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vivo acquisition of two different types of aminoglycoside resistance by a single strain of Klebsiella pneumoniae causing severe infection.
    Murray BE; Moellering RC
    Ann Intern Med; 1982 Feb; 96(2):176-80. PubMed ID: 7036812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycoside resistance in Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    McNeill WF; John JF; Twitty JA
    Am J Clin Pathol; 1984 Jun; 81(6):742-7. PubMed ID: 6428216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M
    Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
    Reyonolds AV; Hamilton-Miller JM; Brumfitt W
    J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S; Vera D; Ramírez-Ronda CH
    Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacterial resistance to aminoglycoside antibiotics].
    Kettner M; Macicková T
    Bratisl Lek Listy; 1992 Apr; 93(4):175-8. PubMed ID: 1393633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel multidrug resistance plasmid isolated from an Escherichia coli strain resistant to aminoglycosides.
    Sun H; Li S; Xie Z; Yang F; Sun Y; Zhu Y; Zhao X; Jiang S
    J Antimicrob Chemother; 2012 Jul; 67(7):1635-8. PubMed ID: 22499999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.
    Acar JF; Witchitz JL; Goldstein F; Talbot JN; Le Goffic F
    J Infect Dis; 1976 Nov; 134 SUPPL():S280-5. PubMed ID: 825587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonspecific aminoglycoside cross-resistance of Serratia marcescens.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(4):204-13. PubMed ID: 378576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity of various semisynthetic aminoglycoside antibiotics on gentamicin-sensitive and gentamicin-resistant bacterial populations].
    Zemelman R; Bello H; Mondaca MA
    Rev Med Chil; 1983 Mar; 111(3):255-61. PubMed ID: 6648106
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New aminoglycosides effective with regard to resistant bacteria].
    Gauze GF
    Antibiotiki; 1980 Sep; 25(9):710-4. PubMed ID: 6998372
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility of Enterococcus faecalis to twelve antibiotics, time-kill assays, and high-level aminoglycoside resistance in a university hospital in Argentina.
    Predari SC; Gutiérrez MA; Ribas C; Molinari GS; Santoianni JE
    Rev Argent Microbiol; 1991; 23(2):67-78. PubMed ID: 1815269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
    Wallace RJ; Hull SI; Bobey DG; Price KE; Swenson JM; Steele LC; Christensen L
    Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal resistance of an istamycin producer, Streptomyces tenjimariensis, to aminoglycoside antibiotics.
    Yamamoto H; Hotta K; Okami Y; Umezawa H
    Biochem Biophys Res Commun; 1981 Jun; 100(3):1396-401. PubMed ID: 7271807
    [No Abstract]   [Full Text] [Related]  

  • 18. Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism.
    Krogstad DJ; Korfhagen TR; Moellering RC; Wennersten C; Swartz MN
    J Clin Invest; 1978 Aug; 62(2):480-6. PubMed ID: 97312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies in aminoglycoside use and impact upon resistance.
    Acar JF; Goldstein FW; Menard R; Bleriot JP
    Am J Med; 1986 Jun; 80(6B):82-7. PubMed ID: 3637052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycoside resistance: a worldwide perspective.
    Young LS; Hindler J
    Am J Med; 1986 Jun; 80(6B):15-21. PubMed ID: 3089000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.